Rituximab as first line treatment for MALT lymphoma of extraocular muscles
dc.contributor.author | Benetatos, L. | en |
dc.contributor.author | Alymara, V. | en |
dc.contributor.author | Asproudis, I. | en |
dc.contributor.author | Bourantas, K. L. | en |
dc.date.accessioned | 2015-11-24T18:53:18Z | |
dc.date.available | 2015-11-24T18:53:18Z | |
dc.identifier.issn | 0939-5555 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/18537 | |
dc.rights | Default Licence | - |
dc.subject | Antibodies, Monoclonal/*administration & dosage | en |
dc.subject | Antibodies, Monoclonal, Murine-Derived | en |
dc.subject | Antineoplastic Agents/*administration & dosage | en |
dc.subject | Humans | en |
dc.subject | Lymphoma, B-Cell, Marginal Zone/*drug therapy/pathology | en |
dc.subject | Male | en |
dc.subject | Middle Aged | en |
dc.subject | Muscle Neoplasms/*drug therapy/pathology | en |
dc.subject | *Oculomotor Muscles/pathology | en |
dc.subject | Remission Induction | en |
dc.subject | Stomach Neoplasms/drug therapy/pathology | en |
dc.subject | Time Factors | en |
dc.title | Rituximab as first line treatment for MALT lymphoma of extraocular muscles | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.primary | 10.1007/s00277-006-0134-0 | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/16691396 | - |
heal.identifier.secondary | http://www.springerlink.com/content/f3t8784117343k47/fulltext.pdf | - |
heal.journalName | Ann Hematol | en |
heal.journalType | peer-reviewed | - |
heal.language | en | - |
heal.publicationDate | 2006 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: